Skip to main content
Fig. 5 | BMC Microbiology

Fig. 5

From: Optimizing the synthesis of yeast Beta-glucan via response surface methodology for nanotechnology application

Fig. 5

Cytotoxicity of different concentrations of β-glucan nanoparticles on HepG2 cell line. A HepG2-Normal cells treated with zero concentration of β-glucan nanoparticles. B HepG2-Normal cells treated with 1000 µg/ml of β-glucan nanoparticles. C HepG2-Cancer cells treated with zero concentration of β-glucan nanoparticles. D HepG2-Cancer cells treated with 1000 µg/ml of β-glucan nanoparticles

Back to article page

BMC Microbiology

ISSN: 1471-2180

Contact us